VTYX (Ventyx Biosciences) Forward P/E Multiple
Ventyx Biosciences specializes in developing innovative treatments to combat inflammatory processes. This trading chart with the 0.00 indicator demonstrates the dynamics of the company, which optimizes the search for new molecules through synergy with scientific centers. Meanwhile, the biopharmaceutical sector operates within a stable legal framework in the US and Europe, remaining unaffected by global trade conflicts.
Analytical breakdowns for Ventyx Biosciences
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
VTYX - Company Net Income|Expected Profit Ventyx Biosciences|VTYX - Price to Earnings Multiple|Projected Price to Earnings Ventyx Bio|VTYX - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio Ventyx Biosciences Inc.|VTYX - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Ventyx Biosciences|VTYX - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months ventyxbio.com|VTYX - Earnings per share increase in current year|Earnings growth forecast for next year Ventyx Biosciences
- total revenue and sales volume data:
Summary company analytics:ventyxbio.com
The forward P/E for Ventyx Biosciences (VTYX) is calculated as the ratio of the company's market capitalization to its projected net income. This metric determines the cost of one dollar of expected earnings, reflecting market optimism regarding growth rates. The potential for monopoly pricing power of innovative psoriasis therapy drugs justifies a high earnings premium. By analyzing the forward P/E valuation trends of Ventyx Biosciences (VTYX), an investor can identify if the asset is overbought. This allows for the avoidance of overpaying amidst temporary price fluctuations.
Competitors of Ventyx Biosciences (VTYX)
Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (Abivax SA)|Market Cap to Projected Earnings admabiologics.com (ADMA)|PTGX - Future Price to Earnings|Immunovant Inc (IMVT) - Projected Price to Earnings|Kiniksa Corp (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols, S.A.|Projected Price to Earnings ADPT|Forward P/E Multiple celldex.com|Future Price to Earnings Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Price to Future Earnings Ratio|Forward P/E Multiple VERA (veratx.com)|Dianthus Pharma (DNTH) - Projected Price to Earnings Ratio|PHVS - Future Price to Earnings|ABCL - Forward P/E Multiple|Tourmaline (TRML) - Future Price to Earnings|Precigen - Future Price to Earnings Multiple|PHAR (Pharming Group NV) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics|Future Price to Earnings Upstream Bio Inc (UPB)|Forward P/E Multiple zenasbio.com (ZBIO)|Future Price to Earnings Immunome Corp IMNM|Forward P/E Multiple Gossamer Bio Inc GOSS|KALV - Future Price to Earnings|Future Price to Earnings Multiple SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Projected Price to Earnings|Savara Inc. - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals, Inc.) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|ENGN - Projected Price to Earnings Ratio|Forward P/E Multiple RAPT (rapt.com)|Market Cap to Future Earnings Ratio JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Kyverna Therapeutics Inc.|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|Future Price to Earnings Theratechnologies, Inc.|Projected Price to Earnings Ratio Avalo Therapeutics AVTX|Forward P/E Multiple ELDN|AGEN (Agenus, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Projected Price to Earnings Ratio|ATYR: Projected Price to Earnings|adagene.com (ADAG) - Projected Price to Earnings|Ikena Oncology (IMA) - Future Price to Earnings|Projected Price to Earnings Shattuck Labs, Inc.|Future Price to Earnings equilliumbio.com|Projected Price to Earnings connectbiopharm.com (CNTB)|Forward P/E Multiple IMUX|Market Cap to Projected Earnings Atara Bio|Future Price to Earnings InflaRx N.V. IFRX|X4 Pharmaceuticals - Future Price to Earnings|ACET: Projected Price to Earnings|Future Price to Earnings Multiple CELU (celularity.com)|INMB: Forward P/E Multiple|BRNS: Market Cap to Future Earnings Ratio|KZR (Kezar Life Sciences, Inc.) - Forward P/E Multiple|SAB Biotherapeutics Inc. (SABS) - Market Cap to Projected Earnings|Forward P/E Multiple AKTX|Future Price to Earnings ENLV (Enlivex Therapeutics Ltd)|Future Price to Earnings Q32 Bio Inc. QTTB|GOVX - Projected Price to Earnings|EDSA - Future Price to Earnings|Projected Price to Earnings Ratio iBio|CARM: Forward P/E Multiple|Price to Expected Earnings Ratio XTLB (XTL Biopharmaceuticals, Ltd.)|Future Price to Earnings boltbio.com|Forward P/E Multiple HCW Biologics|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt Inc.)|Market Cap to Projected Earnings GRI Bio, Inc. (GRI)|XRTX - Future Price to Earnings|reshapelifesciences.com (HIND) - Projected Price to Earnings|REVB: Forward P/E Multiple|Indaptus Therapeutics, Inc. - Future Price to Earnings Multiple|Future Price to Earnings Scinai|Projected Price to Earnings Ratio CalciMedica, Inc. CALI|Future Price to Earnings Affimed NV (AFMD)|Forward P/E Multiple Allakos Inc (ALLK)|Future Price to Earnings hookipapharma.com HOOK|Forward P/E Multiple IGM Biosciences, Inc. IGMS|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple
